BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

Terms: = Colorectal cancer AND CEACAM5, CEA AND Treatment
1507 results:

  • 1. Prognostic factors associated with early recurrence following liver resection for colorectal liver metastases: a systematic review and meta-analysis.
    Tian Y; Wang Y; Wen N; Wang S; Li B; Liu G
    BMC Cancer; 2024 Apr; 24(1):426. PubMed ID: 38584263
    [TBL] [Abstract] [Full Text] [Related]  

  • 2. Clinical study on simultaneous resection of liver metastases combined with hyperthermic intraperitoneal chemotherapy for synchronous colorectal cancer liver metastasis.
    Li W; Ren H; Mou H; Li J; Dong L; Li G; Xing M
    J Gastrointest Surg; 2024 Apr; 28(4):425-433. PubMed ID: 38583892
    [TBL] [Abstract] [Full Text] [Related]  

  • 3. Construction and validation of artificial intelligence pathomics models for predicting pathological staging in colorectal cancer: Using multimodal data and clinical variables.
    Tan Y; Liu R; Xue JW; Feng Z
    Cancer Med; 2024 Apr; 13(7):e6947. PubMed ID: 38545828
    [TBL] [Abstract] [Full Text] [Related]  

  • 4. Efficacy and safety of natural killer cells injection combined with XELOX chemotherapy in postoperative patients with stage III colorectal cancer in China: a prospective randomised controlled clinical trial study protocol.
    Geng S; Yu X; Yu S
    BMJ Open; 2024 Mar; 14(3):e080377. PubMed ID: 38531576
    [TBL] [Abstract] [Full Text] [Related]  

  • 5. Predictive effect of the systemic inflammation response index (SIRI) on the efficacy and prognosis of neoadjuvant chemoradiotherapy in patients with locally advanced rectal cancer.
    Ding Y; Liu Z; Li J; Niu W; Li C; Yu B
    BMC Surg; 2024 Mar; 24(1):89. PubMed ID: 38481180
    [TBL] [Abstract] [Full Text] [Related]  

  • 6. Predictive nomograms of repeat intrahepatic recurrence and overall survival after radiofrequency ablation of recurrent colorectal liver metastases.
    Wang JC; Jiang BB; Zhang ZY; Liu YH; Shao LJ; Wang S; Yang W; Wu W; Yan K
    Int J Hyperthermia; 2024; 41(1):2323152. PubMed ID: 38465646
    [TBL] [Abstract] [Full Text] [Related]  

  • 7. Evaluating the role of wound-healing genes in conjunction with stool routine and serum tumor markers for colorectal cancer diagnosis and prognostic implications.
    Yu K; Fang X
    Int Wound J; 2024 Mar; 21(3):e14768. PubMed ID: 38446012
    [TBL] [Abstract] [Full Text] [Related]  

  • 8. A prediction nomogram for perineural invasion in colorectal cancer patients: a retrospective study.
    Que Y; Wu R; Li H; Lu J
    BMC Surg; 2024 Mar; 24(1):80. PubMed ID: 38439014
    [TBL] [Abstract] [Full Text] [Related]  

  • 9. Development and validation of comprehensive nomograms from the SEER database for predicting early mortality in metastatic rectal cancer patients.
    Li Y; Tao T; Liu Y
    BMC Gastroenterol; 2024 Feb; 24(1):89. PubMed ID: 38408896
    [TBL] [Abstract] [Full Text] [Related]  

  • 10. The clinical relevance of adjuvant chemotherapy in locally advanced rectal cancer patients achieving near pathological complete response following neoadjuvant chemoradiotherapy: Insights from ypT stage.
    Cai Y; Chen M; Ye F; Liu Z; Luo S; Huang L; Kang L
    Eur J Surg Oncol; 2024 Apr; 50(4):108001. PubMed ID: 38364330
    [TBL] [Abstract] [Full Text] [Related]  

  • 11. [Liver transplantation for treatment of nonresectable primary and secondary liver malignancies : Hepatocellular and cholangiocellular carcinomas and colorectal liver metastases].
    Guba M; Werner J
    Chirurgie (Heidelb); 2024 Apr; 95(4):268-273. PubMed ID: 38329517
    [TBL] [Abstract] [Full Text] [Related]  

  • 12. [A Case of Sigmoid Colon cancer with Simultaneous Solitary Adrenal Metastasis Refractory to Preoperative Diagnosis].
    Saito T; Shibutani M; Fukuoka T; Kasashima H; Kitayama K; Tamura T; Toyokawa T; Ree S; Tanaka H; Kato M; Hirayama Y; Matsue T; Masuda K; Uchida J; Maeda K
    Gan To Kagaku Ryoho; 2023 Dec; 50(13):1557-1559. PubMed ID: 38303340
    [TBL] [Abstract] [Full Text] [Related]  

  • 13. [A Case of Long-Term Survival with Metachronous Hepatic and Pulmonary Metastases from Transverse Colon cancer by Multidisciplinary treatment].
    Hara T; Okano M; Hata T; Takayama O; Kim Y; Imamoto H; Hasegawa J
    Gan To Kagaku Ryoho; 2023 Dec; 50(13):1857-1859. PubMed ID: 38303231
    [TBL] [Abstract] [Full Text] [Related]  

  • 14. The effects of oxaliplatin-based adjuvant chemotherapy in high-risk stage II colon cancer with mismatch repair-deficient: a retrospective study.
    Liao L; Tang J; Hong Z; Jiang W; Li Y; Kong L; Han K; Hou Z; Zhang C; Zhou C; Zhang L; Sui Q; Xiao B; Mei W; Yu J; Yang W; Pan Z; Ding PR
    BMC Cancer; 2024 Feb; 24(1):164. PubMed ID: 38302968
    [TBL] [Abstract] [Full Text] [Related]  

  • 15. Immunotherapy in mismatch repair-deficient metastatic colorectal cancer - Outcome and novel predictive markers.
    Stemmer A; Margalit O; Serpas V; Strauss G; Thomas J; Shah P; Tau N; Levanon K; Shacham-Shmueli E; Kopetz S; Overman M; Boursi B
    Eur J Cancer; 2024 Feb; 198():113495. PubMed ID: 38157568
    [TBL] [Abstract] [Full Text] [Related]  

  • 16. Prediction of locally advanced rectal cancer response to neoadjuvant chemoradiation therapy using volumetric multiparametric MRI-based radiomics.
    El Homsi M; Bane O; Fauveau V; Hectors S; Vietti Violi N; Sylla P; Ko HB; Cuevas J; Carbonell G; Nehlsen A; Vanguri R; Viswanath S; Jambawalikar S; Shaish H; Taouli B
    Abdom Radiol (NY); 2024 Mar; 49(3):791-800. PubMed ID: 38150143
    [TBL] [Abstract] [Full Text] [Related]  

  • 17. The clinical value of a nomogram constructed from cea, CA199, PT, FIB, tumor differentiation and TNM stage in colorectal cancer.
    Wang K; Ma L; Chen L; Jiang Y; Liu N; Cai J; Zhang Y
    Cancer Biomark; 2023; 38(4):537-549. PubMed ID: 37980649
    [TBL] [Abstract] [Full Text] [Related]  

  • 18. Patient-Reported Outcomes, Tumor Markers, and Survival Outcomes in Advanced GI cancer.
    Jarnagin JX; Saraf A; Baiev I; Chi G; van Seventer EE; Mojtahed A; Allen JN; Clark JW; Blaszkowsky L; Giantonio BJ; Weekes CD; Klempner SJ; Franses JW; Roeland EJ; Goyal L; Siravegna G; Horick N; Corcoran RB; Nipp RD; Parikh AR
    JAMA Netw Open; 2023 Nov; 6(11):e2343512. PubMed ID: 37976066
    [TBL] [Abstract] [Full Text] [Related]  

  • 19. Using Machine Learning to Leverage Biomarker Change and Predict colorectal cancer Recurrence.
    Rodriguez PJ; Heagerty PJ; Clark S; Khor S; Chen Y; Haupt E; Hahn EE; Shankaran V; Bansal A
    JCO Clin Cancer Inform; 2023 Sep; 7():e2300066. PubMed ID: 37963310
    [TBL] [Abstract] [Full Text] [Related]  

  • 20. Prognostic Potential of Nectin Expressions in colorectal cancer: An Exploratory Study.
    Kobecki J; Gajdzis P; Mazur G; Chabowski M
    Int J Mol Sci; 2023 Nov; 24(21):. PubMed ID: 37958883
    [TBL] [Abstract] [Full Text] [Related]  


    [Next]

    of 76.